Business Description
Sisram Medical Ltd
ISIN : IL0011418113
Compare
Compare
Traded in other countries / regions
01696.Hong KongSRAMF.USA IPO Date
2020-04-21Description
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.58 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 1.14 | |||||
| Interest Coverage | 20.38 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.48 | |||||
| Beneish M-Score | -2.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.2 | |||||
| 3-Year EBITDA Growth Rate | 21.7 | |||||
| 3-Year EPS without NRI Growth Rate | 31.9 | |||||
| 3-Year FCF Growth Rate | 26.9 | |||||
| 3-Year Book Growth Rate | 9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.92 | |||||
| Quick Ratio | 2 | |||||
| Cash Ratio | 0.8 | |||||
| Days Inventory | 208.08 | |||||
| Days Sales Outstanding | 83.75 | |||||
| Days Payable | 35.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.33 | |||||
| 3-Year Dividend Growth Rate | 16.1 | |||||
| 3-Year Average Share Buyback Ratio | -1.9 | |||||
| Shareholder Yield % | 2.25 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.1 | |||||
| Operating Margin % | 11.71 | |||||
| Net Margin % | 8.77 | |||||
| FCF Margin % | 9.84 | |||||
| ROE % | 7.15 | |||||
| ROA % | 5.34 | |||||
| ROIC % | 7.74 | |||||
| ROC (Joel Greenblatt) % | 26.17 | |||||
| ROCE % | 7.78 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.53 | |||||
| PE Ratio without NRI | 7.53 | |||||
| Shiller PE Ratio | 9.75 | |||||
| Price-to-Owner-Earnings | 10.13 | |||||
| PEG Ratio | 0.53 | |||||
| PS Ratio | 0.66 | |||||
| PB Ratio | 0.53 | |||||
| Price-to-Tangible-Book | 1.25 | |||||
| Price-to-Free-Cash-Flow | 6.72 | |||||
| Price-to-Operating-Cash-Flow | 5.41 | |||||
| EV-to-EBIT | 5.37 | |||||
| EV-to-EBITDA | 5.37 | |||||
| EV-to-Revenue | 0.59 | |||||
| EV-to-FCF | 5.96 | |||||
| Price-to-Projected-FCF | 0.44 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.53 | |||||
| Price-to-Graham-Number | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 2.48 | |||||
| Earnings Yield (Greenblatt) % | 18.62 | |||||
| FCF Yield % | 14.86 | |||||
| Forward Rate of Return (Yacktman) % | 19.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SRAMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sisram Medical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 359.292 | ||
| EPS (TTM) ($) | 0.067 | ||
| Beta | 1.5 | ||
| Volatility % | 0.61 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 3.6 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 3.6 - 3.6 | ||
| Shares Outstanding (Mil) | 468.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sisram Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sisram Medical Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sisram Medical Ltd Frequently Asked Questions
What is Sisram Medical Ltd(SRAMF)'s stock price today?
The current price of SRAMF is $3.60. The 52 week high of SRAMF is $3.60 and 52 week low is $3.60.
When is next earnings date of Sisram Medical Ltd(SRAMF)?
The next earnings date of Sisram Medical Ltd(SRAMF) is .
Does Sisram Medical Ltd(SRAMF) pay dividends? If so, how much?
Sisram Medical Ltd(SRAMF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers